The Kennedy Trust for Rheumatology Research
Patent owner in reexamination·2 ex parte reexams
The Kennedy Trust for Rheumatology Research's patents have been the subject of 2 USPTO ex parte reexaminations. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
213
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (2)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/013,031 | Oct 18, 2013 | 8,383,120 | CONCOMITANT TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF-ALPHA ANTIBODIES AND METHOTREXATE | — | Closed |
| 90/012,881 | Jun 3, 2013 | 7,846,442 | METHODS OF TREATING RHEUMATOID ARTHRITIS WITH AN ANTI-TNF-ALPHA ANTIBODIES AND METHOTREXATE | — | Closed |
See the full reexam picture for The Kennedy Trust for Rheumatology Research
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.